2020-12-29,Oyster Point Pharma to Participate in the 39th Annual J.P. Morgan Healthcare Conference
2020-12-18,Oyster Point Pharma Submits New Drug Application to the U.S. Food and Drug Administration for OC-01 (varenicline) Nasal Spray for the Treatment of Signs and Symptoms of Dry Eye Disease
2020-12-12,Is OYST A Good Stock To Buy Now?
2020-12-07,Oyster Point Pharma Strengthens Executive Leadership Team with the Appointment of Chief Medical and Chief Scientific Officers
2020-12-01,Oyster Point Pharma Submits a Phase 2 Clinical Trial Protocol to Evaluate OC-01 Nasal Spray for Neurotrophic Keratitis (NK)
2020-11-25,Oyster Point Pharma to Attend the Piper Sandler 32nd Annual Virtual Healthcare Conference
2020-11-13,Oyster Point Pharma Announces Clinical Data Presentations on OC-01 Nasal Spray for Dry Eye Disease at the American Academy of Ophthalmology 2020 Virtual Annual Meeting
2020-11-06,"Oyster Point Pharma, Inc. (OYST) Q3 2020 Earnings Call Transcript"
2020-11-05,Oyster Point Pharma Reports Third Quarter 2020 Financial Results and Recent Business Highlights
2020-11-05,Oyster Point Pharma Inc to Host Earnings Call
2020-10-29,"Oyster Point Pharma to Report Third Quarter 2020 Financial Results on November 5, 2020"
2020-10-08,Oyster Point Pharma Announces Board of Directors Leadership Changes and New Appointment as the Company Advances into Next Phase of Growth
2020-09-11,Oyster Point Pharma to Present at the Morgan Stanley Virtual 18th Annual Global Healthcare Conference
2020-08-17,"Chief Commercial Officer John Snisarenko Just Bought 133% More Shares In Oyster Point Pharma, Inc. (NASDAQ:OYST)"
2020-08-11,"Do Institutions Own Oyster Point Pharma, Inc. (NASDAQ:OYST) Shares?"
2020-08-11,We're Not Very Worried About Oyster Point Pharma's (NASDAQ:OYST) Cash Burn Rate
2020-08-05,Oyster Point Pharma Reports Second Quarter 2020 Financial Results and Recent Business Highlights
2020-07-31,"Oyster Point Pharma to Report Second Quarter 2020 Financial Results on August 5, 2020"
2020-06-01,"Is Oyster Point Pharma, Inc. (OYST) A Good Stock To Buy?"
2020-05-28,How Oyster Point (OYST) Stock Stands Out in a Strong Industry
2020-05-24,3 Top Pharma Stocks to Buy Right Now
2020-05-19,Oyster Point Pharma Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares
2020-05-15,Oyster Point Pharma Announces Pricing of an Upsized Offering of Common Stock
2020-05-12,Oyster Point Pharma Proposed Public Offering of Common Stock
2020-05-11,"Oyster Point Pharma, Inc. (OYST) Q1 2020 Earnings Call Transcript"
2020-05-11,Oyster Point Pharma Announces Positive Results in ONSET-2 Phase 3 Trial of OC-01 Nasal Spray for the Treatment of the Signs and Symptoms of Dry Eye Disease
2020-05-11,Oyster Point Pharma Reports First Quarter 2020 Financial Results and Recent Business Highlights
2020-05-04,"Oyster Point Pharma to Report First Quarter 2020 Financial Results on May 11, 2020"
2020-03-30,Oyster Point Pharma Completes Enrollment in ONSET-2 Pivotal Phase 3 Clinical Trial of OC-01 Nasal Spray for Dry Eye Disease and Provides COVID-19 Business Update
2020-02-27,Oyster Point Pharma Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights
2020-02-24,"Oyster Point Pharma to Report Fourth Quarter and Full Year 2019 Financial Results on February 27, 2020"
2020-02-24,Oyster Point Pharma to Present at the Cowen 40th Annual Healthcare Conference
2020-01-12,Oyster Point Pharmas OC-01 Nasal Spray Meets Primary Endpoint in Phase 2 Mystic Trial in Subjects With Dry Eye Disease
2019-12-24,"The Daily Biotech Pulse: NewLink Genetics Licenses Ovarian Cancer Dug, Correvio Awaits FDA Verdict"
2019-12-23,"Oyster Point Pharma Announces Addition to the Russell 2000®, Russell 3000® and Russell Microcap® Indexes"
2019-12-17,Oyster Point Pharma to Present at the 38th Annual J.P. Morgan Healthcare Conference
2019-12-03,Biotech IPO Frenzy Brings in 3 Stocks to Buy
2019-12-03,Oyster Point Pharma Reports Third Quarter 2019 Financial Results and Recent Business Highlights
2019-11-25,Oyster Point Pharma to Present at the 31st Annual Piper Jaffray Healthcare Conference
2019-11-22,Oyster Point Pharma Announces Positive Top-Line Results From the Phase 1 ZEN Study of Its Lead Nicotinic Agonist Nasal Spray in Development for the Treatment of Dry Eye Disease
2019-11-05,Oyster Point Pharma Announces Closing of Initial Public Offering
2019-10-28,"IPO Outlook For The Week: Chinese Media, Chinese Real Estate, Dry-Eye Therapy"
